Niki BioSolutions, Inc.: director Laura A Philips received 8,000 shares

What happened

• Laura A Philips, a director, received a grant of 8,000 derivative securities (options) on Jul 22, 2026 at an exercise price of $0.00, total reported value $0.00.

Key details

• Transaction date and price: Jul 22, 2026; $0.00 per share.
• Amount of securities beneficially owned following the reported transaction: not reported in the filing.
• Vesting (footnote F1): 2,000 options vested immediately upon the closing of the merger; the remaining 6,000 options vest in three equal quarterly installments of 2,000 options each, commencing on the first business day of the first full quarter following the effective date of the merger.
• Filing date and timeliness: Form filed Oct 21, 2026; transaction occurred Jul 22, 2026; filing timeliness: L (late).

Why it may matter

• This filing reports a grant of options (a derivative award), not a market purchase or sale.
• The filing does not show why the insider traded or why the company acted.